Parallax Volatility Advisers
ARNA

Parallax Volatility Advisers’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Parallax Volatility Advisers’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,642
Closed -$2.1M – 3668
2021
Q4 		$2.1M Buy
+22,642
New +$1.49M ﹤0.01% 1624
2019
Q1 		– Sell
-130
Closed -$5.96K – 4370
2018
Q4 		$5K Buy
130
+79
+155% +$3.1K ﹤0.01% 2579
2018
Q3 		$2K Sell
51
-27,227
-100% -$1.1M ﹤0.01% 2446
2018
Q2 		$1.19M Buy
27,278
+27,227
+53,386% +$1.17M ﹤0.01% 1055
2018
Q1 		$2K Sell
51
-5,913
-99% -$230K ﹤0.01% 2055
2017
Q4 		$203K Buy
+5,964
New +$170K ﹤0.01% 2277

Parallax Volatility Advisers's ARNA Position: Q1 2022 in Review

Parallax Volatility Advisers sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 22,642 shares — an estimated $2.1M sold.

Parallax Volatility Advisers first reported a position in ARNA in Q4 2017 and held it in 6 quarters. The position peaked at $2.1M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • Parallax Volatility Advisers reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Parallax Volatility Advisers sold 22,642 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.1M.
  • Parallax Volatility Advisers first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 6 quarters.
  • Parallax Volatility Advisers's Arena Pharmaceuticals Inc position peaked at $2.1M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Parallax Volatility Advisers's 13F filing for Q1 2022, filed 16 May 2022.